Novel method for rapid in-situ hybridization of HER2 using non-contact alternating-current electric-field mixing

Human epidermal growth factor receptor 2 (HER2)-targeted agents are an effective approach to treating HER2-positive breast cancer patients. However, the lack of survival benefit in HER2-negative patients as well as the toxic effects and high cost of the drugs highlight the need for accurate and prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yoshitaro, Imai, Kazuhiro, Nakamura, Ryuta, Nanjo, Hiroshi, Terata, Kaori, Konno, Hayato, Akagami, Yoichi, Minamiya, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957099/
https://www.ncbi.nlm.nih.gov/pubmed/27443187
http://dx.doi.org/10.1038/srep30034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957099/
https://www.ncbi.nlm.nih.gov/pubmed/27443187
http://dx.doi.org/10.1038/srep30034

Ejemplares similares